6533b857fe1ef96bd12b3b70

RESEARCH PRODUCT

Factors Affecting Hesitancy to mRNA and Viral Vector COVID-19 Vaccines among College Students in Italy

Lucia CraxìLaura SalernoGianluca Lo CocoEmanuele Amodio

subject

Agreeablenessmedicine.medical_specialty2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Immunologyvaccine hesitancy; COVID-19; mRNA vaccines; viral vector vaccines; college students; ItalyArticleViral vectorOddsDrug DiscoverymedicinePharmacology (medical)Pharmacologybusiness.industryPublic healthcollege studentsRCOVID-19mRNA vaccinesInfectious DiseasesItalyviral vector vaccinesvaccine hesitancyMedicinebusinessDemography

description

Vaccine hesitancy (VH) may be significant in jeopardizing efforts to mass containment of COVID-19. A cross-sectional survey was carried out on a sample of 2667 Italian college students, before the COVID-19 vaccines became available for this age group (from 7 May to 31 May 2021). An online survey was created to obtain information about socio-demographic, health-related, and psychological factors linked to mRNA and viral vector COVID-19 vaccines. Statistically significant higher VH (30.4%) and vaccine resistance (12.2%) rates were found for viral vector than mRNA COVID-19 vaccines (7.2% and 1.0%, respectively; p < 0.001). Factors related to viral vector VH were partially different from those related to mRNA VH. Students with greater endorsement on conspiracy statements and negative attitudes toward the vaccine had higher odds of being vaccine-hesitant or -resistant. Students who had received a previous COVID-19 test and who scored higher on the agreeableness personality dimension had lower odds to be vaccine-hesitant or -resistant. The willingness to choose the vaccine was related to the viral vector but not to the mRNA VH. Taking into consideration the factors involved in vaccine hesitancy/resistance in college students could represent a key public health strategy to increase vaccine coverage and reduce viral spreading.

10.3390/vaccines9080927https://www.mdpi.com/2076-393X/9/8/927